Aktive farmaceutiske ingredienser
Gestagen og østrogen | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Progesteron | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolon | In-house |
Kosher | 145-13-1 |
Medroxyprogesteron Acetat | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrolacetat | CP/EP/USP | DMF i gang | 595-33-5 |
Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
Cyproteronacetat | CP/EP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | CEP/GMP | 797-63-7 |
Drospirenon | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Østradiol | CP/EP/USP | DMF/GMP | 35380-71-3 |
Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
Ethinylestradiol | CP/EP/USP | GMP | 57-63-6 |
Østradiol Valerat | CP | DMF | 979-32-8 |
Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | EP | CEP | 65928-58-7 |
Fulvestrant | In-house | Under R&D | 129453-61-8 |
Exemestan | EP/USP | Under R&D | 107868-30-4 |
androgen | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abirateronacetat | CP/USP | DMF/WC | 154229-18-2 |
Testosteron | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosteron undecanoat | CP | DMF/WC | 5949-44-0 |
Testosteron Cypionate | USP | Under R&D | 58-20-8 |
DHEA (prasteron) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In-house | DMF i gang | 19608-29-8 |
Kortikalt hormon | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Budesonid | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonid | USP | DMF/GMP | 638-94-8 |
Eplerenon | EP | CEP i gang | 107724-20-9 |
Methylprednisolon | CP/EP/USP | DMF/GMP | 83-43-2 |
Methylprednisolon Hemisuccinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
Fluticasonpropionat | CP/EP/USP | DMF | 80474-14-2 |
Flutikasonfuroat | In-house | DMF i gang | 397864-44-7 |
Mometasonfuroat |
EP/USP |
DMF i gang |
Vandfri (83919-23-7) Monohydrat (141646-00-6) |
Andre | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Oxcarbazepin | CP/EP/USP | CEP/FDA | 28721-07-5 |
Eslicarbazepinacetat | In-house | DMF | 236395-14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochlorid | USP | DMF | 175865-59-5 |
Oseltamivir fosfat | CP/EP/USP | DMF | 204255-11-8 |
Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
Nintedanib Esylate | In-house | DMF/FDA | 656247-18-6 |
Revefenacin | In-house | DMF | 864750-70-9 |
Mirabegron | In-house | DMF | 223673-61-8 |
Escitalopram Oxalat | EP/USP/CP | DMF i gang | 219861-08-2 |
Cariprazin hydrochlorid | In-house | DMF | 1083076-69-0 |
Lasmiditansuccinat | In-house | DMF | 439239-92-6 |
Luliconazol | In-house | DMF | 187164-19-8 |
Apalutami | In-house | DMF i gang | 956104-40-8 |
Tadalafil | EP/USP/CP | Under R&D | 171596-29-5 |
Relugolix | In-house | DMF i gang | 737789-87-6 |
Phloroglucinol | CP | DMF | 108-73-6 |
Ursodeoxycholsyre | EP/USP/JP | Under R&D | 128-13-2 |
Omega-3-syre ethylethere 90 |
EP/USP |
DMF i gang |
—— |
Mellemkædede triglycerider |
CP/USP/EP |
DMF |
—— |
Benzalkoniumchlorid |
USP/EP/JP |
CEP i gang |
8001-54-5 |
Olivenolie (til injektion) |
CP/USP/EP/JP |
DMF i gang |
8001-25-0 |
Ægfosfolipider (til injektion) |
CP/USP/EP |
DMF |
93685-90-6 |
MELLEMMÅLTID |
In-house |
DMF i gang |
203787-91-1 |
Abiraterone Acetate har CP,USP specifikationer. DMF, toilet til rådighed.
Drospirenon har EP,USP specifikationer. DMF godkendt.
Medroxyprogesteronacetat har USPãEPã IPãJP og KP. DMF, GMP er tilgængelig.
Oxcarbazepin har CP, EP og USP specifikationer. CEP og DMF tilgængelige, GMP godkendt.
Ganciclovir har CP,EP, USP-specifikation.DMF og GMP godkendt.
Nintedanib Esylate har in-house specifikation.DMF tilgængelig.